Altria (MO) edged higher in Monday trading as investors reacted to the FDA decision on December 19 to issue Marketing Granted ...

Altria Group stock faces declining cigarette sales and legal challenges. Here's why most investors should probably look elsewhere.

MO doubles its buyback to $2 billion, extending it to 2026, after heavy 2025 repurchases, signaling confidence in cash flows amid cigarette volume declines.

Altria Group, Inc. (NYSE:MO) is included among the Best Stocks for a Dividend Achievers List. On December 19, Bank of America ...

Altria's annual dividend is $4.24 per share ($1.06 quarterly), meaning you'd need to own 472 shares to receive $500 in annual ...

Tobacco giant Altria Group ( MO +0.88%) has done quite well in 2025. The stock is up by roughly 10% since January, or 16% if you include dividends. That hasn't been the norm in recent years: After ...

Dec 11 (Reuters) - Altria ‌said ​on Thursday that ‌CEO Billy Gifford, who has ​led the tobacco giant since ‍2020, will retire in May, ​and will be succeeded by ​finance ⁠head Salvatore Mancuso.

The Food and Drug Administration on Friday issued marketing granted orders to six On Plus nicotine pouch products. They are the first authorizations under a pilot program launched in September to ...

The U.S. Food and Drug Administration has authorized six on! PLUS nicotine pouch products for sale. These pouches are made by ...

Altria’s board of directors has elected Salvatore “Sal” Mancuso to become CEO upon Gifford’s retirement on May 14, 2026.

The U.S. Food and Drug Administration (FDA) has authorized the marketing of six on! PLUS nicotine pouch products owned by ...

Read here for more on top big-yield investment opportunities, including a deep dive on Altria. Get insights on qualified ...